Asia Deal Watch: Astellas Invests In Taysha, Gets Rights To Two AAV Gene Therapies

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, and Joseph Haas

Plus deals involving Takeda/Zedira/Dr. Falk, Lupin/Sunovion, Eucure/Syncromune, Hetero/Johnson & Johnson, Nitto Denko/Omega, Harbour BioMed/CSPC and Pregene/Bone Therapeutics.

Asia Deal Watch
• Source: Alamy

More from Deal Watch

More from Deals